Thorarinsdottir, Hulda
Kander, Thomas
Johansson, Dorota
Nilsson, Bo
Klarin, Bengt
Sanchez, Javier
Funding for this research was provided by:
Vinova, the Swedish governmental innovation agency (2012-01252)
Swedish regional research grant
PF7 EU framework program HEALTH (602699)
Lund University
Article History
Received: 11 October 2021
Accepted: 12 May 2022
First Online: 21 May 2022
Competing interests
: This study was part of a national project entitled Innovation against Infection (in Swedish: <i>Innovation Mot Infektion</i> [IMI]) and was performed in collaboration with the following: Skåne University Hospital, Lund, Sweden; Uppsala University Hospital, Uppsala, Sweden; and Bactiguard AB, Stockholm, Sweden. Javier Sanchez and Dorota Johansson were employees at Bactiguard AB, Stockholm at the time of the study. The authors have no other conflict of interest.